▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / NPHC

NPHC — NUTRA PHARMA CORP

—
· Materials · Chemicals · CIK 1119643 ·
Last close
$0.00
Market Cap
—
52W High
$0.00
52W Low
$0.00
ADV30
1,028,750
Next earnings
—
Selectis Health, Inc. owns and operates, through wholly-owned subsidiaries Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the US. The Company acquires, develops, leases and manages healthcare real estate and provides healthcare operations through our wholly-owned subsidiaries. Our portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. We will make investments within our healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008 (RIDEA), which represents investments in senior housing operations utilizing the structure permitted by RIDEA and (vi) owning healthcare operations. Selectis Health, Inc. was established and incorporated on June 08, 1978 in Utah, USA.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 48,214 18,975 -379,249 -459,675 616,518 21,844 17,878,499
Dec 2025 54,066 -11,907 -465,914 -488,526 584,558 12,181 17,409,864
Sep 2025 98,704 64,576 -356,076 -523,520 709,853 3,603 17,060,633
Jun 2025 122,143 75,628 -290,529 369,577 859,068 79,069 16,692,328

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,086,749
Investing CF
$-25,000
Financing CF
$1,119,750
CapEx
$-26,052
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-06-14

Balance + Analyst (yfinance extras)

Retained Earnings
$-78,738,204
Inventory
$23,506
Receivables
$374,192
ST Investments
$17,600
EBIT TTM
$-659,517
Pretax Income TTM
$-1,102,144
Interest Exp TTM
$442,627
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 385,307 -1,462,338 -2,047,392 584,558 17,409,864 — -1,163,964
Dec 2024 392,150 -878,421 -1,285,663 599,495 15,407,409 — -423,959
Dec 2023 594,880 -781,514 -1,393,356 640,397 14,408,705 — -550,036
Dec 2022 438,274 -1,835,608 8,176,871 754,913 13,132,365 — -762,432
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
PG PROCTER & GAMBLE Co $348.38B $149.61 —
LIN LINDE PLC $242.07B $523.57 —
UL UNILEVER PLC $127.59B $58.92 —
ECL ECOLAB INC. $74.70B $265.41 —
CL COLGATE PALMOLIVE CO $71.58B $89.45 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →